Wendy Smith-Begolka, Senior Vice President of Scientific and Clinical Affairs of NEA, discusses key findings from the patient-focused drug development (PFDD) meeting, an important opportunity for people living with eczema and caregivers to share their perspectives on the impact of the condition and the need for treatment options that better address their needs.